Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

Sattva S. Neelapu; Sudhakar Tummala; Partow Kebriaei; William G. Wierda; Frederick L. Locke; Yi Lin; Nitin Jain; Naval Daver; Alison Gulbis; Sherry Adkins; Katayoun Rezvani; Patrick Hwu; Elizabeth J. Shpall

doi:10.1038/nrclinonc.2018.20

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Sudhakar Tummala(The University of Texas MD Anderson Cancer Center), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), William G. Wierda(The University of Texas MD Anderson Cancer Center), Frederick L. Locke(Moffitt Cancer Center), Yi Lin(Mayo Clinic in Arizona), Nitin Jain(The University of Texas MD Anderson Cancer Center), Naval Daver(The University of Texas MD Anderson Cancer Center), Alison Gulbis(The University of Texas MD Anderson Cancer Center), Sherry Adkins(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(The University of Texas MD Anderson Cancer Center)

Nature Reviews Clinical Oncology

February 13, 2018

10.1038/nrclinonc.2018.20

Cited by 138

Abstract

Related Papers

No related papers found

Powered by citation graph analysis